The 5th Canadian Symposium on Hepatitis C Virus: we are not done yet—remaining challenges in hepatitis C
N van Buuren, L Fradette, J Grebely… - Canadian Journal of …, 2016 - Wiley Online Library
Hepatitis C virus (HCV) affects approximately 268,000 Canadians and results in more years
of life lost than any other infectious disease in the country. Both the Canadian Institutes of …
of life lost than any other infectious disease in the country. Both the Canadian Institutes of …
Proteomic analysis of microbial infections
L Zhang, D Xiao, K Cheng - Molecular Medical Microbiology, 2024 - Elsevier
Proteomics is the study of proteins and/or their interactions with other molecules in a
biological system. Proteomics is getting more and more popular due to the easy-to-use and …
biological system. Proteomics is getting more and more popular due to the easy-to-use and …
High-throughput approaches to unravel hepatitis C virus-host interactions
CC Colpitts, H El-Saghire, N Pochet, C Schuster… - Virus research, 2016 - Elsevier
Hepatitis C virus (HCV) remains a major global health burden, with more than 130 million
individuals chronically infected and at risk for the development of hepatocellular carcinoma …
individuals chronically infected and at risk for the development of hepatocellular carcinoma …
Inhibition of Hepatitis C Replication by Targeting the Molecular Chaperone Hsp90: Synthesis and Biological Evaluation of 4,5,6,7‐Tetrahydrobenzo[1,2‐d]thiazole …
Cellular chaperones that belong to the heat‐shock protein 90 (Hsp90) family are a
prerequisite for successful viral propagation for most viruses. The hepatitis C virus (HCV) …
prerequisite for successful viral propagation for most viruses. The hepatitis C virus (HCV) …
An integrative approach to virus–host protein–protein interactions
Since cell regulation and protein expression can be dramatically altered upon infection by
viruses, studying the mechanisms by which viruses infect cells and the regulatory networks …
viruses, studying the mechanisms by which viruses infect cells and the regulatory networks …
Proteomics methods for discovering viral–host interactions
AA Georges, L Frappier - Methods, 2015 - Elsevier
The functions of many viral proteins involve direct interactions with specific host proteins.
Therefore considerable insight into the functions of a viral protein and its mechanisms of …
Therefore considerable insight into the functions of a viral protein and its mechanisms of …
Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C
I Esposito, S Marciano, J Trinks - Expert Opinion on Drug …, 2018 - Taylor & Francis
Introduction: Many reports have evaluated the clinical efficacy and safety of the fixed-dose
all-oral combination of daclatasvir, asunaprevir, and beclabuvir (DCV-TRIO), which was …
all-oral combination of daclatasvir, asunaprevir, and beclabuvir (DCV-TRIO), which was …
HCV NS3/4A protease inhibitors and the road to effective direct-acting antiviral therapies
N Tremblay, AY Park, D Lamarre - Hepatitis C Virus II: Infection and …, 2016 - Springer
Hepatitis C virus (HCV) currently infects over 185 million individuals around the world. Its
persistence causes infected individuals to enter a chronic phase where their condition can …
persistence causes infected individuals to enter a chronic phase where their condition can …
Proteomic approaches to analyzing hepatitis C virus biology
Hepatitis C virus (HCV) is a major cause of liver disease worldwide. Acute infection often
progresses to chronicity resulting frequently in fibrosis, cirrhosis, and in rare cases, in the …
progresses to chronicity resulting frequently in fibrosis, cirrhosis, and in rare cases, in the …
Asunaprevir for hepatitis C: a safety evaluation
I Gentile, E Zappulo, AR Buonomo… - Expert Opinion on …, 2015 - Taylor & Francis
Introduction: The introduction of direct-acting antiviral (DAA) agents has revolutionized the
treatment of hepatitis C virus (HCV) chronic infection. Non-structural 3 protease inhibitors …
treatment of hepatitis C virus (HCV) chronic infection. Non-structural 3 protease inhibitors …